Institutional investors purchased a net $1.8 million shares of INSM during the quarter ended September 2015 and now own 93.66% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMERALD ADVISERS, INC. Bought 290.9 Thousand shares of Insmed Inc
THE VANGUARD GROUP, INC. Bought 254.7 Thousand shares of Insmed Inc
GREEN OWL CAPITAL MANAGEMENT LLC Bought 90.0 Thousand shares of Insmed Inc